Philip P. Connell to Humans
This is a "connection" page, showing publications Philip P. Connell has written about Humans.
Connection Strength
0.451
-
Noncanonical NF-?B factor p100/p52 regulates homologous recombination and modulates sensitivity to DNA-damaging therapy. Nucleic Acids Res. 2022 06 24; 50(11):6251-6263.
Score: 0.027
-
Elevated Radiation Therapy Toxicity in the Setting of Germline PTEN Mutation. Pract Radiat Oncol. 2019 Nov; 9(6):492-495.
Score: 0.022
-
Optimization of Drug Candidates That Inhibit the D-Loop Activity of RAD51. ChemMedChem. 2019 05 17; 14(10):1031-1040.
Score: 0.022
-
Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast Cancer. Clin Cancer Res. 2017 Aug 01; 23(15):4493-4500.
Score: 0.019
-
Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy? ChemMedChem. 2016 11 21; 11(22):2468-2473.
Score: 0.018
-
Strategies to Overcome Late Complications from Radiotherapy for Childhood Head and Neck Cancers. Oral Maxillofac Surg Clin North Am. 2016 Feb; 28(1):115-26.
Score: 0.017
-
The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors. Cancer Res. 2014 Jul 01; 74(13):3546-55.
Score: 0.015
-
DNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapy. Sci Transl Med. 2014 Mar 26; 6(229):229ra42.
Score: 0.015
-
Real-time solution measurement of RAD51- and RecA-mediated strand assimilation without background annealing. Nucleic Acids Res. 2013 Jul; 41(13):e130.
Score: 0.014
-
An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity. J Med Chem. 2013 Jan 10; 56(1):254-63.
Score: 0.014
-
RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells. Nucleic Acids Res. 2012 Aug; 40(15):7347-57.
Score: 0.013
-
A downside to apoptosis in cancer therapy? Nat Med. 2011 Jul 07; 17(7):780-2.
Score: 0.013
-
Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):1147-53.
Score: 0.011
-
Advances in radiotherapy and implications for the next century: a historical perspective. Cancer Res. 2009 Jan 15; 69(2):383-92.
Score: 0.011
-
A chemical compound that stimulates the human homologous recombination protein RAD51. Proc Natl Acad Sci U S A. 2008 Oct 14; 105(41):15848-53.
Score: 0.010
-
Radiotherapy for pediatric brain tumors: when and how. Expert Rev Anticancer Ther. 2007 Dec; 7(12 Suppl):S69-77.
Score: 0.010
-
Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers. Am J Clin Oncol. 2007 Jun; 30(3):258-63.
Score: 0.010
-
Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. Int J Oncol. 2006 May; 28(5):1113-9.
Score: 0.009
-
Long term follow up of nasolacrimal intubation in adults. Br J Ophthalmol. 2006 Apr; 90(4):435-6.
Score: 0.009
-
Relevance and irrelevance of DNA damage response to radiotherapy. DNA Repair (Amst). 2004 Aug-Sep; 3(8-9):1245-51.
Score: 0.008
-
Investigating ethnic differences in sexual health: focus groups with young people. Sex Transm Infect. 2004 Aug; 80(4):300-5.
Score: 0.008
-
Gene therapy: the challenges of translating laboratory research into clinical practice. J Clin Oncol. 2003 Jun 15; 21(12):2230-1.
Score: 0.007
-
STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2023 01; 7:e2200273.
Score: 0.007
-
Team Approach: Management of Pathologic Fractures. JBJS Rev. 2023 Jan 01; 11(1).
Score: 0.007
-
Mechanisms of distinctive mismatch tolerance between Rad51 and Dmc1 in homologous recombination. Nucleic Acids Res. 2021 12 16; 49(22):13135-13149.
Score: 0.007
-
qRT-PCR-based DNA homologous recombination-associated 4-gene score predicts pathologic complete response to platinum-based neoadjuvant chemotherapy in triple-negative breast cancer. Breast Cancer Res Treat. 2022 Jan; 191(2):335-344.
Score: 0.006
-
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
Score: 0.006
-
Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 2001 Aug 01; 50(5):1145-53.
Score: 0.006
-
Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma. Int J Radiat Oncol Biol Phys. 2001 Aug 01; 50(5):1154-60.
Score: 0.006
-
Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experience. J Clin Oncol. 2001 Jan 01; 19(1):54-61.
Score: 0.006
-
Age as a prognostic factor for recurrence in patients with endometrial carcinoma. Gynecol Oncol. 2000 Oct; 79(1):79-85.
Score: 0.006
-
Do conventional pathologic features lose their prognostic significance following postoperative radiation therapy in pathologic stage I-II endometrial adenocarcinoma? Int J Cancer. 2000 Aug 20; 90(4):224-30.
Score: 0.006
-
Radiation-Induced Sarcoma After Heterotopic Ossification Prophylaxis: A Case Report. JBJS Case Connect. 2019 Dec; 9(4):e0146.
Score: 0.006
-
Race and clinical outcome in endometrial carcinoma. Obstet Gynecol. 1999 Nov; 94(5 Pt 1):713-20.
Score: 0.006
-
Caution in interpreting biochemical control rates after treatment of prostate cancer: length of follow-up influences results. Urology. 1999 Nov; 54(5):875-9.
Score: 0.006
-
The significance of adnexal involvement in endometrial carcinoma. Gynecol Oncol. 1999 Jul; 74(1):74-9.
Score: 0.006
-
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma. Mol Cancer Ther. 2019 03; 18(3):507-516.
Score: 0.005
-
Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non-Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy. Clin Lung Cancer. 2018 03; 19(2):e227-e233.
Score: 0.005
-
Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51. J Med Chem. 2016 05 26; 59(10):4511-25.
Score: 0.004
-
Dual and Opposite Effects of hRAD51 Chemical Modulation on HIV-1 Integration. Chem Biol. 2015 Jun 18; 22(6):712-23.
Score: 0.004
-
RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells. Nucleic Acids Res. 2015 Mar 31; 43(6):3180-96.
Score: 0.004
-
New paradigms and future challenges in radiation oncology: an update of biological targets and technology. Sci Transl Med. 2013 Feb 20; 5(173):173sr2.
Score: 0.004
-
An analysis of patient characteristics and clinical outcomes in primary pulmonary sarcoma. J Thorac Oncol. 2013 Feb; 8(2):147-51.
Score: 0.004
-
Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer. J Thorac Oncol. 2012 Feb; 7(2):376-81.
Score: 0.003
-
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer. 2012 Jun 01; 118(11):2962-70.
Score: 0.003
-
Stimulation of the human RAD51 nucleofilament restricts HIV-1 integration in vitro and in infected cells. J Virol. 2012 Jan; 86(1):513-26.
Score: 0.003
-
Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):446-50.
Score: 0.003
-
The Yin and Yang of treating BRCA-deficient tumors. Cell. 2008 Mar 21; 132(6):919-20.
Score: 0.003
-
A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 1):515-22.
Score: 0.002
-
Outcome of endometrial carcinoma patients with involvement of the uterine serosa. Gynecol Oncol. 2001 Aug; 82(2):338-43.
Score: 0.002
-
Analysis of the role of adjuvant chemotherapy for invasive carcinoma of the esophagus. Am J Clin Oncol. 2000 Dec; 23(6):554-8.
Score: 0.002
-
Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am J Clin Oncol. 2000 Oct; 23(5):476-80.
Score: 0.002
-
Synchronous ovarian and endometrial malignancies. Am J Clin Oncol. 2000 Oct; 23(5):521-5.
Score: 0.002
-
One versus two intracavitary brachytherapy applications in early-stage cervical cancer patients undergoing definitive radiation therapy. Gynecol Oncol. 2000 Jul; 78(1):32-8.
Score: 0.001
-
Acute problems during low-dose-rate intracavitary brachytherapy for cervical carcinoma. Gynecol Oncol. 2000 Jan; 76(1):67-72.
Score: 0.001
-
Surgery and postoperative radiation therapy in stage II endometrial carcinoma. Am J Clin Oncol. 1999 Aug; 22(4):338-43.
Score: 0.001
-
External pelvic radiation therapy in stage IC endometrial carcinoma. Obstet Gynecol. 1999 Apr; 93(4):599-602.
Score: 0.001
-
What is the optimal treatment volume in Hodgkin's disease patients undergoing high-dose chemotherapy and adjuvant radiation therapy? Radiat Oncol Investig. 1999; 7(6):353-9.
Score: 0.001
-
Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol. 1998 Nov; 71(2):151-8.
Score: 0.001